6533b834fe1ef96bd129d796
RESEARCH PRODUCT
Current Surgical Treatment Standards for Esophageal and Esophagogastric Junction Cancer
Thomas SchmidtChristian A. GutschowSeung Hon ChonJunichi AkiyamaMickael ChevallayMinoa JungFelix BerlthStefan Mönigsubject
medicine.medical_specialtyEsophageal Neoplasms610 Medicine & healthGenetics and Molecular BiologyTransthoracic esophagectomyAdenocarcinomaGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineEsophagusHistory and Philosophy of Science1300 General Biochemistry Genetics and Molecular BiologyGastricmedicineHumansEsophagogastric junctionEsophagusNeoplasm MetastasisSurgical treatmentCancer10217 Clinic for Visceral and Transplantation Surgery1207 History and Philosophy of Scienceddc:617business.industryGeneral NeuroscienceAnastomosis SurgicalCancer2800 General NeuroscienceEsophageal cancermedicine.diseaseSurgeryEsophagectomyEsophagogastric junctionmedicine.anatomical_structureCervical lymph nodes030220 oncology & carcinogenesisGeneral BiochemistryAdenocarcinoma030211 gastroenterology & hepatologySurgeryEsophagogastric Junctionbusinessdescription
A number of different surgical techniques for the treatment of cancer of the esophagus and the esophagogastric junction have been proposed. Guidelines generally recommend a transthoracic approach for esophageal cancer, including Siewert type I tumors. In tumors of the proximal esophageal third, transthoracic esophagectomy may be extended to a three-field approach, including resection of cervical lymph nodes. However, the choice between transthoracic esophagectomy with intrathoracic anastomosis (Ivor Lewis esophagectomy) and the three-incision approach with cervical esophago-gastrostomy (McKeown esophagectomy) remains controversial, with guidelines varying among different countries. Furthermore, it is commonly accepted that Siewert type III tumors should be treated by extended total gastrectomy with transhiatal resection of the lower esophagus, whereas currently no consensus exists regarding the optimal surgical approach for the treatment of Siewert type II adenocarcinoma. Likewise, there is a major controversy regarding palliative and potentially curative treatment modalities in oligometastatic disease. This review deals with current surgical treatment standards for cancer of the esophagus and the eosphagogastric junction, including discussion of ongoing trials.
year | journal | country | edition | language |
---|---|---|---|---|
2020-05-15 |